Perrigo Co. PLC has added plans for launching two additional private label versions of the Mucinex OTC line within six months. Added to its pending roll out of a Nexium 24HR equivalent, the moves continue buffing the shine on Perrigo's position as the dominant consumer health generics provider.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?